Community Health Systems (CHS), one of the largest hospital chains in the U.S., has announced the sale of four rural hospitals as it tries to relieve some of its $15 billion debt.

Medtronic has received approval from the U.S. Food and Drug Administration (FDA) for a potentially revolutionary device that monitors glucose levels and delivers insulin automatically. The MiniMed 670G works as an “artificial pancreas," because its sensors constantly monitor insulin levels within the body and inject the dose needed accordingly.

Consolidating health systems is an ongoing trend as the industry moves toward value-based care, but it doesn’t always work. Just ask Integrated Health Network of Wisconsin.

The World Health Organization confirmed that both North and South America are free of endemic measles, the first region to be certified as such, according to a recent report from The New York Times.

GE Healthcare has launched its five.eight accelerator program for improving healthcare in developing countries. The program will assist healthcare startups in improving the quality and accessibility of healthcare technologies for patients otherwise unable to receive care.

A new treatment for Crohn’s disease was approved by the FDA this week, one that aims to serve as an alternative for patients who are intolerant of immunomodulators or corticosteroids.

Pfizer has decided not to divide itself into two companies, one focusing on older drugs and another on patent-protected products, according to the Wall Street Journal.

Physicians are faced with the proposition from paper to digital technology at a rapid pace. A study conducted by the American Medical Association (AMA) found that many physicians have common “musts” for the use of digital tool and what they expect from the digital tools in return.